Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation
El. Nelson et al., Cycling of human dendritic cell effector phenotypes in response to TNF-alpha: modification of the current 'maturation' paradigm and implications for in vivo immunoregulation, FASEB J, 13(14), 1999, pp. 2021-2030
Dendritic cells (DCs) are potent antigen presenting cells reported to under
go irreversible functional 'maturation' in response to inflammatory signals
such as TNF-alpha. The current paradigm holds that this DC maturation even
t is required for full functional capacity and represents terminal differen
tiation of this cell type, culminating in apoptotic cell death. This provid
es a possible mechanism for avoiding dysregulated immunostimulatory activit
y, but imposes constraints on the capacity of DCs to influence subsequent i
mmune responses and to participate in immunological memory. We report that
the cell surface and functional effects induced by TNF-alpha are reversible
and reinducible. These effects are accompanied by a concordant modulation
of cytokine mRNA expression that includes the induction of proinflammatory
factors (IL-15, IL-12, LT-a!, LT-beta, TNF-alpha, RANTES) which is coincide
nt with the down-regulation of counter-regulatory cytokines (IL-10, TGF-bet
a 1, TGF-beta 2, IL-1 RA, MCP-1). The resultant net effect is a dendritic c
ell activation state characterized by a transient proinflammatory posture.
These results demonstrate that 1) human DCs do not undergo terminal 'matura
tion' in response to TNF-alpha, 2) DC phenotypes are more pleiotropic than
previously thought, and 3) DCs are potential immunoregulatory effector cell
s with implications for control of immune responses in both in vivo and in
vitro systems.-Nelson, E. L., Strobl, S., Subleski, J., Prieto, D., Kopp, W
. C., Nelson, P. J. Cycling of human dendritic cell effector phenotypes in
response to TNF-alpha: modification of the current 'maturation' paradigm an
d implications for in vivo immunoregulation. Cycling of human dendritic cel
l effector phenotypes in response to TNF-alpha modification of the current
'maturation' paradigm and implications for in vivo immunoregulation.